Hormone therapy and ovarian cancer: incidence and survival

scientific article published on 09 February 2008

Hormone therapy and ovarian cancer: incidence and survival is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10552-008-9125-X
P932PMC publication ID2729759
P698PubMed publication ID18264784
P5875ResearchGate publication ID5586904

P50authorPolly A NewcombQ89454622
P2093author name stringAmy Trentham-Dietz
John M Hampton
Karen J Wernli
Kathleen M Egan
P2860cites workHormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesteroneQ77636062
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study CohortQ79182453
Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancerQ79776018
Menopausal hormones and risk of ovarian cancerQ80379715
Impact of hysterectomy on endometrial carcinoma rates in the United StatesQ81481079
Hormone replacement therapy and invasive and borderline epithelial ovarian cancer riskQ81648115
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapyQ81894621
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
A prospective study of postmenopausal hormone use and ovarian cancer riskQ28213056
Statistical methods in cancer research. Volume II--The design and analysis of cohort studiesQ29615413
Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survivalQ32000828
Hormone replacement therapy after epithelial ovarian cancer treatment.Q33937559
National use of postmenopausal hormone therapy: annual trends and response to recent evidenceQ34288307
Ovarian cancer and hormone replacement therapy in the Million Women StudyQ34629811
Hormone replacement therapy and survival after surgery for ovarian cancerQ35178365
Hormone replacement therapy and risk of epithelial ovarian cancer.Q36619751
Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010Q36695133
Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cellsQ40780316
Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participantsQ40885870
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trialQ44602959
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyQ46151255
Weight change and risk of postmenopausal breast cancer (United States).Q47235408
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.Q50672431
Statistical methods in cancer research. Volume I - The analysis of case-control studies.Q52768696
Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.Q53824136
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.Q55038814
Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survivalQ57027279
Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish womenQ57199859
A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancerQ64130667
Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control studyQ71270652
Estrogen replacement therapy and fatal ovarian cancerQ72157255
Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trialQ73004908
Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control studyQ73384879
Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and WalesQ73761682
Menopausal hormone replacement therapy and risk of ovarian cancerQ74460475
Estrogen replacement therapy and ovarian cancerQ75231048
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysisQ77168041
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)605-613
P577publication date2008-02-09
P1433published inCancer Causes & ControlQ325957
P1476titleHormone therapy and ovarian cancer: incidence and survival
P478volume19

Reverse relations

cites work (P2860)
Q46300341Estrone sulfatase activity in patients with advanced ovarian cancer
Q42754883Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma
Q37532651Investigation of mammographic breast density as a risk factor for ovarian cancer
Q92071291Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis
Q36039829Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study
Q43864747Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition
Q97528612Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
Q91690126Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome
Q64079499Ovarian cancer in the world: epidemiology and risk factors
Q37017056Ovarian cancer stroma: pathophysiology and the roles in cancer development
Q40227579Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women
Q39324480Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases
Q36443891Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study
Q34622294SGO White Paper on ovarian cancer: etiology, screening and surveillance

Search more.